-
-
-
-
-
-
-
Jefferies Assumes Olema Pharmaceuticals (OLMA) at Buy
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Olema Pharmaceuticals (OLMA): Roche Ph3 outcome "not optimal for OLMA stock near term"
-
-
-
-
-
-
-
Citi Opens 90-Day Positive Catalyst Call on Olema Pharmaceuticals (OLMA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
-
-
-
-
-
-
-
Olema Pharmaceuticals (OLMA) option IV near upper end of range
-
-
-
-
-
-
-
Goldman Sachs Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
445,260 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

